Active substance
Pindolol
- US FDA 15
- Health Canada 3
- US price lines 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| PINDOLOL | 5MG; 10MG | tablet · oral | AUROBINDO PHARMA USA | Prescription | 3 Sep 1992 |
| PINDOLOL | 10MG; 5MG | tablet · oral | ANI PHARMS | Prescription | 29 Mar 1993 |
| PINDOLOL | 5MG; 10MG | tablet · oral | SUN PHARM INDUSTRIES | Prescription | 27 Jan 1994 |
| PINDOLOL | 5MG; 10MG | tablet · oral | MPP PHARMA | Prescription | 13 Jan 2016 |
| PINDOLOL | 5MG; 10MG | tablet · oral | UNICHEM | Prescription | 1 Aug 2019 |
| VISKEN | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | NOVARTIS | Discontinued | 3 Sep 1982 |
| PINDOLOL | 5MG | tablet · oral | MYLAN PHARMS INC | Discontinued | 24 Sep 1992 |
| PINDOLOL | 10MG | tablet · oral | MYLAN PHARMS INC | Discontinued | 24 Sep 1992 |
| PINDOLOL | 5MG; 10MG | tablet · oral | COSETTE PHARMS NC | Discontinued | 26 Feb 1993 |
| PINDOLOL | 5MG; 10MG | tablet · oral | PUREPAC PHARM | Discontinued | 28 Apr 1993 |
| PINDOLOL | 5MG; 10MG | tablet · oral | COSETTE PHARMS NC | Discontinued | 31 Oct 1993 |
| PINDOLOL | 5MG; 10MG | tablet · oral | WATSON LABS | Discontinued | 27 Feb 1995 |
| PINDOLOL | 5MG; 10MG | tablet · oral | NOSTRUM LABS | Discontinued | 28 Oct 1996 |
| PINDOLOL | 5MG; 10MG | tablet · oral | COSETTE PHARMS NC | Discontinued | 17 Apr 1997 |
| PINDOLOL | 5MG; 10MG | tablet · oral | ZYDUS PHARMS | Discontinued | 18 Aug 2017 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| TEVA-PINDOLOL | 00869007 | 5 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-PINDOLOL | 00869015 | 10 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-PINDOLOL | 00869023 | 15 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | PINDOLOL 10 MG TABLET | $0.85399 | per EA | 23 Sep 2026 |
| US NADAC | PINDOLOL 5 MG TABLET | $0.59694 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Pindolol
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.